Home › Companies › Thermo Fisher Scientific Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Thermo Fisher Scientific Inc.’s Form 8-K, filed 2026-05-26 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Thermo Fisher Scientific Inc. in the interactive database Compare manager voting policies
These tallies are Thermo Fisher Scientific Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-26 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Marc N. Casper | 294,015,478 | 20,501,640 | 1,202,257 | -- | -- | Majority: yes |
| Elect Director: Nelson J. Chai | 293,142,241 | 21,615,744 | 961,390 | -- | -- | Majority: yes |
| Elect Director: Ruby R. Chandy | 312,259,374 | 2,490,403 | 969,598 | -- | -- | Majority: yes |
| Elect Director: C. Martin Harris | 285,543,740 | 28,753,064 | 1,422,571 | -- | -- | Majority: yes |
| Elect Director: Tyler Jacks | 304,372,357 | 10,373,697 | 973,321 | -- | -- | Majority: yes |
| Elect Director: Jennifer M. Johnson | 304,583,443 | 10,151,215 | 984,717 | -- | -- | Majority: yes |
| Elect Director: R. Alexandra Keith | 308,290,311 | 6,269,824 | 1,159,240 | -- | -- | Majority: yes |
| Elect Director: Karen S. Lynch | 308,933,071 | 5,811,374 | 974,930 | -- | -- | Majority: yes |
| Elect Director: Debora L. Spar | 314,426,121 | 311,821 | 981,433 | -- | -- | Majority: yes |
| Elect Director: Scott M. Sperling | 292,218,754 | 22,524,675 | 975,946 | -- | -- | Majority: yes |
| Elect Director: Dion J. Weisler | 281,791,656 | 32,960,105 | 967,614 | -- | -- | Majority: yes |
| Proposal 2: A non-binding, advisory proposal on the compensation of the Company's named executive officers was not approved. | 99,928,178 | 214,525,673 | 1,265,524 | -- | -- | Majority: no |
| Proposal 3: The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified. | 296,866,709 | 36,064,900 | 999,237 | -- | -- | Majority: yes |
Source: Thermo Fisher Scientific Inc., Form 8-K, filed with the SEC on 2026-05-26 — read the filing on EDGAR.
Each item below shows how the 1,664 asset managers that disclosed a Thermo Fisher Scientific Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Thermo Fisher Scientific Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2026-05-20.
Combines 33 wordings of this item as funds reported it.
32% Majority: no · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Proposal 2: A non-binding, advisory proposal on the compensation of the Company's named executive officers was not approved.”): 99,928,178 for, 214,525,673 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 27% for, 58% against (85% of the company cast a for/against vote).
The 1,631 asset managers below cast 37% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,949,493 | 35,459,729 | 5 | 0 | Against |
| BlackRock | 22,508,195 | 3,552,173 | 0 | 0 | For |
| Fidelity | 23,356,670 | 667,314 | 0 | 0 | For |
| Capital Group | 7,503,825 | 14,804,852 | 32 | 0 | Against |
| T. Rowe Price | 10,698,060 | 268,369 | 0 | 0 | For |
| State Street | 59,045 | 10,542,501 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 8,375,438 | 0 | 0 | 0 | For |
| Putnam | 18,920 | 6,742,288 | 0 | 0 | Against |
| Charles Schwab | 4,639 | 5,780,033 | 0 | 0 | Against |
| Capital Research Global Investors | 0 | 4,408,936 | 0 | 0 | Against |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3,700,988 | 17,160 | 0 | 0 | For |
| Invesco | 86 | 3,580,662 | 0 | 0 | Against |
| Northern Trust | 0 | 3,065,295 | 0 | 0 | Against |
| Parnassus | 0 | 2,776,024 | 0 | 0 | Against |
| Fisher Asset Management, LLC | 0 | 2,669,460 | 0 | 0 | Against |
| 1832 Asset Management L.P. | 803,908 | 1,689,392 | 0 | 0 | Against |
| Union Investment Management GmbH | 0 | 2,375,722 | 0 | 0 | Against |
| Grantham, Mayo, Van Otterloo & Co. LLC | 2,258,296 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 2,224,809 | 0 | 0 | Against |
| Goldman Sachs | 2,156,621 | 0 | 0 | 0 | For |
| Unisphere Establishment | 2,060,000 | 0 | 0 | 0 | For |
| PRIMECAP MANAGEMENT CO/CA/ | 1,979,646 | 0 | 0 | 0 | For |
| APG Asset Management US Inc. | 0 | 1,962,090 | 0 | 0 | Against |
| EdgePoint Investment Group Inc. | 1,897,066 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 1,631 asset managers. See all 1,631 in the interactive database.
Meeting held 2026-05-20.
Combines 9 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Proposal 3: The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified.”): 296,866,709 for, 36,064,900 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 80% for, 10% against (90% of the company cast a for/against vote).
The 262 asset managers below cast 98% of the shares they voted on this item FOR (110,120,582 for, 1,870,405 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,453,651 | 149,265 | 4 | 0 | For |
| Fidelity | 14,802,678 | 0 | 0 | 0 | For |
| Capital Group | 11,592,321 | 0 | 0 | 0 | For |
| BlackRock | 9,296,949 | 8,525 | 0 | 0 | For |
| State Street | 4,391,626 | 8,079 | 0 | 0 | For |
| T. Rowe Price | 3,874,431 | 0 | 0 | 0 | For |
| Charles Schwab | 2,859,529 | 0 | 0 | 0 | For |
| Putnam | 2,707,840 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
| MFS | 1,551,994 | 0 | 0 | 0 | For |
| TIAA | 1,524,832 | 0 | 0 | 0 | For |
| Invesco | 1,372,576 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,350,851 | 0 | 0 | 0 | For |
| Parnassus | 0 | 1,318,730 | 0 | 0 | Against |
| Dimensional | 977,778 | 0 | 0 | 0 | For |
| JPMorgan | 887,554 | 0 | 0 | 0 | For |
| AMCAP FUND | 797,341 | 0 | 0 | 0 | For |
| GMO | 762,123 | 0 | 0 | 0 | For |
| Legg Mason | 751,930 | 0 | 0 | 0 | For |
| Jackson National | 723,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 719,980 | 0 | 0 | 0 | For |
| John Hancock | 594,368 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 575,310 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 574,620 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 541,772 | 0 | 0 | 0 | For |
Showing the 25 largest of 262 asset managers. See all 262 in the interactive database.
Meeting held 2026-05-20.
Combines 8 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Marc N. Casper”): 294,015,478 for, 20,501,640 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 79% for, 6% against (85% of the company cast a for/against vote).
The 260 asset managers below cast 99.9% of the shares they voted on this item FOR (111,961,059 for, 15,583 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,602,651 | 261 | 6 | 0 | For |
| Fidelity | 14,802,678 | 0 | 0 | 0 | For |
| Capital Group | 11,592,321 | 0 | 0 | 0 | For |
| BlackRock | 9,305,474 | 0 | 0 | 0 | For |
| State Street | 4,399,675 | 30 | 0 | 0 | For |
| T. Rowe Price | 3,874,431 | 0 | 0 | 0 | For |
| Charles Schwab | 2,859,529 | 0 | 0 | 0 | For |
| Putnam | 2,707,840 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
| MFS | 1,551,994 | 0 | 0 | 0 | For |
| TIAA | 1,524,832 | 0 | 0 | 0 | For |
| Invesco | 1,372,576 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,350,851 | 0 | 0 | 0 | For |
| Parnassus | 1,318,730 | 0 | 0 | 0 | For |
| Dimensional | 977,778 | 0 | 0 | 0 | For |
| JPMorgan | 887,554 | 0 | 0 | 0 | For |
| AMCAP FUND | 797,341 | 0 | 0 | 0 | For |
| GMO | 762,123 | 0 | 0 | 0 | For |
| Legg Mason | 751,930 | 0 | 0 | 0 | For |
| Jackson National | 723,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 719,980 | 0 | 0 | 0 | For |
| John Hancock | 594,368 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 575,310 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 574,620 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 541,772 | 0 | 0 | 0 | For |
Showing the 25 largest of 260 asset managers. See all 260 in the interactive database.
Meeting held 2026-05-20.
Combines 8 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Nelson J. Chai”): 293,142,241 for, 21,615,744 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 79% for, 6% against (85% of the company cast a for/against vote).
The 260 asset managers below cast 99.5% of the shares they voted on this item FOR (111,465,043 for, 514,478 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,602,665 | 251 | 4 | 0 | For |
| Fidelity | 14,802,678 | 0 | 0 | 0 | For |
| Capital Group | 11,592,321 | 0 | 0 | 0 | For |
| BlackRock | 9,305,474 | 0 | 0 | 0 | For |
| State Street | 4,399,652 | 53 | 0 | 0 | For |
| T. Rowe Price | 3,874,431 | 0 | 0 | 0 | For |
| Charles Schwab | 2,859,529 | 0 | 0 | 0 | For |
| Putnam | 2,707,840 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
| MFS | 1,551,994 | 0 | 0 | 0 | For |
| TIAA | 1,524,832 | 0 | 0 | 0 | For |
| Invesco | 1,372,576 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,350,851 | 0 | 0 | 0 | For |
| Parnassus | 1,318,730 | 0 | 0 | 0 | For |
| Dimensional | 977,778 | 0 | 0 | 0 | For |
| JPMorgan | 887,554 | 0 | 0 | 0 | For |
| AMCAP FUND | 797,341 | 0 | 0 | 0 | For |
| GMO | 762,123 | 0 | 0 | 0 | For |
| Legg Mason | 751,930 | 0 | 0 | 0 | For |
| Jackson National | 723,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 719,980 | 0 | 0 | 0 | For |
| John Hancock | 594,368 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 575,310 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 574,620 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 541,772 | 0 | 0 | 0 | For |
Showing the 25 largest of 260 asset managers. See all 260 in the interactive database.
Meeting held 2026-05-20.
Combines 8 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Ruby R. Chandy”): 312,259,374 for, 2,490,403 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 84% for, 0.7% against (85% of the company cast a for/against vote).
The 260 asset managers below cast 99.9% of the shares they voted on this item FOR (111,964,201 for, 15,317 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,602,889 | 25 | 4 | 0 | For |
| Fidelity | 14,802,678 | 0 | 0 | 0 | For |
| Capital Group | 11,592,321 | 0 | 0 | 0 | For |
| BlackRock | 9,305,474 | 0 | 0 | 0 | For |
| State Street | 4,399,705 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,874,431 | 0 | 0 | 0 | For |
| Charles Schwab | 2,859,529 | 0 | 0 | 0 | For |
| Putnam | 2,707,840 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
| MFS | 1,551,994 | 0 | 0 | 0 | For |
| TIAA | 1,524,832 | 0 | 0 | 0 | For |
| Invesco | 1,372,576 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,350,851 | 0 | 0 | 0 | For |
| Parnassus | 1,318,730 | 0 | 0 | 0 | For |
| Dimensional | 977,778 | 0 | 0 | 0 | For |
| JPMorgan | 887,554 | 0 | 0 | 0 | For |
| AMCAP FUND | 797,341 | 0 | 0 | 0 | For |
| GMO | 762,123 | 0 | 0 | 0 | For |
| Legg Mason | 751,930 | 0 | 0 | 0 | For |
| Jackson National | 723,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 719,980 | 0 | 0 | 0 | For |
| John Hancock | 594,368 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 575,310 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 574,620 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 541,772 | 0 | 0 | 0 | For |
Showing the 25 largest of 260 asset managers. See all 260 in the interactive database.
Meeting held 2026-05-20.
Combines 8 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: C. Martin Harris”): 285,543,740 for, 28,753,064 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 77% for, 8% against (85% of the company cast a for/against vote).
The 260 asset managers below cast 99.5% of the shares they voted on this item FOR (111,443,309 for, 536,206 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,602,555 | 355 | 9 | 0 | For |
| Fidelity | 14,802,678 | 0 | 0 | 0 | For |
| Capital Group | 11,592,321 | 0 | 0 | 0 | For |
| BlackRock | 9,305,474 | 0 | 0 | 0 | For |
| State Street | 4,399,652 | 53 | 0 | 0 | For |
| T. Rowe Price | 3,874,431 | 0 | 0 | 0 | For |
| Charles Schwab | 2,859,529 | 0 | 0 | 0 | For |
| Putnam | 2,707,840 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
| MFS | 1,551,994 | 0 | 0 | 0 | For |
| TIAA | 1,524,832 | 0 | 0 | 0 | For |
| Invesco | 1,372,576 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,350,851 | 0 | 0 | 0 | For |
| Parnassus | 1,318,730 | 0 | 0 | 0 | For |
| Dimensional | 977,778 | 0 | 0 | 0 | For |
| JPMorgan | 887,554 | 0 | 0 | 0 | For |
| AMCAP FUND | 797,341 | 0 | 0 | 0 | For |
| GMO | 762,123 | 0 | 0 | 0 | For |
| Legg Mason | 751,930 | 0 | 0 | 0 | For |
| Jackson National | 723,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 719,980 | 0 | 0 | 0 | For |
| John Hancock | 594,368 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 575,310 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 574,620 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 541,772 | 0 | 0 | 0 | For |
Showing the 25 largest of 260 asset managers. See all 260 in the interactive database.
Meeting held 2026-05-20.
Combines 7 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Tyler Jacks”): 304,372,357 for, 10,373,697 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 82% for, 3% against (85% of the company cast a for/against vote).
The 260 asset managers below cast 99.9% of the shares they voted on this item FOR (111,908,085 for, 71,435 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,602,780 | 135 | 4 | 0 | For |
| Fidelity | 14,802,678 | 0 | 0 | 0 | For |
| Capital Group | 11,592,321 | 0 | 0 | 0 | For |
| BlackRock | 9,305,474 | 0 | 0 | 0 | For |
| State Street | 4,399,675 | 30 | 0 | 0 | For |
| T. Rowe Price | 3,874,431 | 0 | 0 | 0 | For |
| Charles Schwab | 2,859,529 | 0 | 0 | 0 | For |
| Putnam | 2,707,840 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
| MFS | 1,551,994 | 0 | 0 | 0 | For |
| TIAA | 1,524,832 | 0 | 0 | 0 | For |
| Invesco | 1,372,576 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,350,851 | 0 | 0 | 0 | For |
| Parnassus | 1,318,730 | 0 | 0 | 0 | For |
| Dimensional | 977,778 | 0 | 0 | 0 | For |
| JPMorgan | 887,554 | 0 | 0 | 0 | For |
| AMCAP FUND | 797,341 | 0 | 0 | 0 | For |
| GMO | 762,123 | 0 | 0 | 0 | For |
| Legg Mason | 751,930 | 0 | 0 | 0 | For |
| Jackson National | 723,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 719,980 | 0 | 0 | 0 | For |
| John Hancock | 594,368 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 575,310 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 574,620 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 541,772 | 0 | 0 | 0 | For |
Showing the 25 largest of 260 asset managers. See all 260 in the interactive database.
Meeting held 2026-05-20.
Combines 7 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Jennifer M. Johnson”): 304,583,443 for, 10,151,215 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 82% for, 3% against (85% of the company cast a for/against vote).
The 260 asset managers below cast 99.3% of the shares they voted on this item FOR (111,267,219 for, 712,301 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,571,945 | 30,971 | 4 | 0 | For |
| Fidelity | 14,802,678 | 0 | 0 | 0 | For |
| Capital Group | 11,592,321 | 0 | 0 | 0 | For |
| BlackRock | 9,304,188 | 1,286 | 0 | 0 | For |
| State Street | 4,399,705 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,874,431 | 0 | 0 | 0 | For |
| Charles Schwab | 2,859,529 | 0 | 0 | 0 | For |
| Putnam | 2,707,840 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
| MFS | 1,551,994 | 0 | 0 | 0 | For |
| TIAA | 1,524,832 | 0 | 0 | 0 | For |
| Invesco | 1,372,576 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,350,851 | 0 | 0 | 0 | For |
| Parnassus | 1,318,730 | 0 | 0 | 0 | For |
| Dimensional | 977,778 | 0 | 0 | 0 | For |
| JPMorgan | 887,554 | 0 | 0 | 0 | For |
| AMCAP FUND | 797,341 | 0 | 0 | 0 | For |
| GMO | 762,123 | 0 | 0 | 0 | For |
| Legg Mason | 751,930 | 0 | 0 | 0 | For |
| Jackson National | 723,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 719,980 | 0 | 0 | 0 | For |
| John Hancock | 594,368 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 575,310 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 574,620 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 541,772 | 0 | 0 | 0 | For |
Showing the 25 largest of 260 asset managers. See all 260 in the interactive database.
Meeting held 2026-05-20.
Combines 8 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: R. Alexandra Keith”): 308,290,311 for, 6,269,824 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 83% for, 2% against (85% of the company cast a for/against vote).
The 260 asset managers below cast 99.5% of the shares they voted on this item FOR (111,458,668 for, 520,848 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,602,851 | 61 | 6 | 0 | For |
| Fidelity | 14,802,678 | 0 | 0 | 0 | For |
| Capital Group | 11,592,321 | 0 | 0 | 0 | For |
| BlackRock | 9,305,474 | 0 | 0 | 0 | For |
| State Street | 4,399,705 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,874,431 | 0 | 0 | 0 | For |
| Charles Schwab | 2,859,529 | 0 | 0 | 0 | For |
| Putnam | 2,707,840 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
| MFS | 1,551,994 | 0 | 0 | 0 | For |
| TIAA | 1,524,832 | 0 | 0 | 0 | For |
| Invesco | 1,372,576 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,350,851 | 0 | 0 | 0 | For |
| Parnassus | 1,318,730 | 0 | 0 | 0 | For |
| Dimensional | 977,778 | 0 | 0 | 0 | For |
| JPMorgan | 887,554 | 0 | 0 | 0 | For |
| AMCAP FUND | 797,341 | 0 | 0 | 0 | For |
| GMO | 762,123 | 0 | 0 | 0 | For |
| Legg Mason | 751,930 | 0 | 0 | 0 | For |
| Jackson National | 723,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 719,980 | 0 | 0 | 0 | For |
| John Hancock | 594,368 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 575,310 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 574,620 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 541,772 | 0 | 0 | 0 | For |
Showing the 25 largest of 260 asset managers. See all 260 in the interactive database.
Meeting held 2026-05-20.
Combines 8 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Karen S. Lynch”): 308,933,071 for, 5,811,374 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 83% for, 2% against (85% of the company cast a for/against vote).
The 260 asset managers below cast 99.9% of the shares they voted on this item FOR (111,910,198 for, 69,321 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,602,861 | 54 | 4 | 0 | For |
| Fidelity | 14,802,678 | 0 | 0 | 0 | For |
| Capital Group | 11,592,321 | 0 | 0 | 0 | For |
| BlackRock | 9,305,474 | 0 | 0 | 0 | For |
| State Street | 4,399,705 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,874,431 | 0 | 0 | 0 | For |
| Charles Schwab | 2,859,529 | 0 | 0 | 0 | For |
| Putnam | 2,707,840 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
| MFS | 1,551,994 | 0 | 0 | 0 | For |
| TIAA | 1,524,832 | 0 | 0 | 0 | For |
| Invesco | 1,372,576 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,350,851 | 0 | 0 | 0 | For |
| Parnassus | 1,318,730 | 0 | 0 | 0 | For |
| Dimensional | 977,778 | 0 | 0 | 0 | For |
| JPMorgan | 887,554 | 0 | 0 | 0 | For |
| AMCAP FUND | 797,341 | 0 | 0 | 0 | For |
| GMO | 762,123 | 0 | 0 | 0 | For |
| Legg Mason | 751,930 | 0 | 0 | 0 | For |
| Jackson National | 723,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 719,980 | 0 | 0 | 0 | For |
| John Hancock | 594,368 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 575,310 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 574,620 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 541,772 | 0 | 0 | 0 | For |
Showing the 25 largest of 260 asset managers. See all 260 in the interactive database.
Meeting held 2026-05-20.
Combines 8 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Debora L. Spar”): 314,426,121 for, 311,821 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 85% for, 0.1% against (85% of the company cast a for/against vote).
The 260 asset managers below cast 99.9% of the shares they voted on this item FOR (111,964,223 for, 15,296 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,602,911 | 4 | 0 | 0 | For |
| Fidelity | 14,802,678 | 0 | 0 | 0 | For |
| Capital Group | 11,592,321 | 0 | 0 | 0 | For |
| BlackRock | 9,305,474 | 0 | 0 | 0 | For |
| State Street | 4,399,705 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,874,431 | 0 | 0 | 0 | For |
| Charles Schwab | 2,859,529 | 0 | 0 | 0 | For |
| Putnam | 2,707,840 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
| MFS | 1,551,994 | 0 | 0 | 0 | For |
| TIAA | 1,524,832 | 0 | 0 | 0 | For |
| Invesco | 1,372,576 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,350,851 | 0 | 0 | 0 | For |
| Parnassus | 1,318,730 | 0 | 0 | 0 | For |
| Dimensional | 977,778 | 0 | 0 | 0 | For |
| JPMorgan | 887,554 | 0 | 0 | 0 | For |
| AMCAP FUND | 797,341 | 0 | 0 | 0 | For |
| GMO | 762,123 | 0 | 0 | 0 | For |
| Legg Mason | 751,930 | 0 | 0 | 0 | For |
| Jackson National | 723,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 719,980 | 0 | 0 | 0 | For |
| John Hancock | 594,368 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 575,310 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 574,620 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 541,772 | 0 | 0 | 0 | For |
Showing the 25 largest of 260 asset managers. See all 260 in the interactive database.
Meeting held 2026-05-20.
Combines 8 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Scott M. Sperling”): 292,218,754 for, 22,524,675 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 79% for, 6% against (85% of the company cast a for/against vote).
The 260 asset managers below cast 99.2% of the shares they voted on this item FOR (111,181,382 for, 798,138 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,602,639 | 276 | 4 | 0 | For |
| Fidelity | 14,802,678 | 0 | 0 | 0 | For |
| Capital Group | 11,592,321 | 0 | 0 | 0 | For |
| BlackRock | 9,305,474 | 0 | 0 | 0 | For |
| State Street | 4,399,652 | 53 | 0 | 0 | For |
| T. Rowe Price | 3,874,431 | 0 | 0 | 0 | For |
| Charles Schwab | 2,859,529 | 0 | 0 | 0 | For |
| Putnam | 2,707,840 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
| MFS | 1,551,994 | 0 | 0 | 0 | For |
| TIAA | 1,524,832 | 0 | 0 | 0 | For |
| Invesco | 1,372,576 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,350,851 | 0 | 0 | 0 | For |
| Parnassus | 1,318,730 | 0 | 0 | 0 | For |
| Dimensional | 977,778 | 0 | 0 | 0 | For |
| JPMorgan | 887,554 | 0 | 0 | 0 | For |
| AMCAP FUND | 797,341 | 0 | 0 | 0 | For |
| GMO | 762,123 | 0 | 0 | 0 | For |
| Legg Mason | 751,930 | 0 | 0 | 0 | For |
| Jackson National | 624,459 | 98,857 | 0 | 0 | For |
| Columbia Threadneedle | 719,980 | 0 | 0 | 0 | For |
| John Hancock | 594,368 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 575,310 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 574,620 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 541,772 | 0 | 0 | 0 | For |
Showing the 25 largest of 260 asset managers. See all 260 in the interactive database.
Meeting held 2026-05-20.
Combines 8 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Elect Director: Dion J. Weisler”): 281,791,656 for, 32,960,105 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 76% for, 9% against (85% of the company cast a for/against vote).
The 260 asset managers below cast 96% of the shares they voted on this item FOR (107,802,994 for, 4,176,526 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 33,602,545 | 371 | 4 | 0 | For |
| Fidelity | 14,688,192 | 114,486 | 0 | 0 | For |
| Capital Group | 11,592,321 | 0 | 0 | 0 | For |
| BlackRock | 9,305,474 | 0 | 0 | 0 | For |
| State Street | 4,399,705 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,874,431 | 0 | 0 | 0 | For |
| Charles Schwab | 3,155 | 2,856,374 | 0 | 0 | Against |
| Putnam | 2,707,840 | 0 | 0 | 0 | For |
| Six Circles Trust | 1,893,726 | 0 | 0 | 0 | For |
| MFS | 1,551,994 | 0 | 0 | 0 | For |
| TIAA | 1,524,832 | 0 | 0 | 0 | For |
| Invesco | 1,372,576 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,350,851 | 0 | 0 | 0 | For |
| Parnassus | 1,318,730 | 0 | 0 | 0 | For |
| Dimensional | 977,778 | 0 | 0 | 0 | For |
| JPMorgan | 887,554 | 0 | 0 | 0 | For |
| AMCAP FUND | 797,341 | 0 | 0 | 0 | For |
| GMO | 762,123 | 0 | 0 | 0 | For |
| Legg Mason | 751,930 | 0 | 0 | 0 | For |
| Jackson National | 723,316 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 719,980 | 0 | 0 | 0 | For |
| John Hancock | 594,368 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 418,922 | 156,388 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 574,620 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 541,772 | 0 | 0 | 0 | For |
Showing the 25 largest of 260 asset managers. See all 260 in the interactive database.
Meeting held 2025-05-21 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 3 wordings of this item as funds reported it.
36% Majority: no · of votes cast
Thermo Fisher Scientific Inc.’s own tally for this item (“Proposal 2: A non-binding, advisory proposal on the compensation of the Company's named executive officers was not approved.”): 111,099,532 for, 201,378,177 against, per its Form 8-K (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 371,621,465 outstanding shares: 30% for, 54.2% against (84% of the company cast a for/against vote).
The 9 asset managers below cast 27% of the shares they voted on this item FOR (53,075 for, 143,482 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PENSIOENFONDS RAIL & OV | 0 | 99,866 | 0 | 0 | Against |
| NORRIS PERNE & FRENCH LLP/MI | 25,016 | 0 | 0 | 0 | For |
| OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC | 24,044 | 0 | 0 | 0 | For |
| Investment Management Corp of Ontario | 0 | 16,992 | 0 | 0 | Against |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 0 | 11,607 | 0 | 0 | Against |
| OSSIAM | 0 | 10,131 | 0 | 0 | Against |
| GLENMEDE FUND INC | 0 | 4,767 | 0 | 0 | Against |
| Slow Capital, Inc. | 4,015 | 0 | 0 | 0 | For |
| FIRST UNITED BANK & TRUST | 0 | 119 | 0 | 0 | Against |
Meeting held 2026-05-20.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 6 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOUR INVESTMENT MANAGEMENT LLC | 3,520 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 2,070 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 1,993 | 0 | 0 | 0 | For |
| VALUED ADVISERS TRUST | 1,750 | 0 | 0 | 0 | For |
| WILLIAMSBURG INVESTMENT TRUST | 900 | 0 | 0 | 0 | For |
| ESL Trust Services, LLC | 15 | 0 | 0 | 0 | For |
Meeting held 2026-05-20.
61% fund support · no official result
The 5 asset managers below cast 61% of the shares they voted on this item FOR (30,716 for, 19,368 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 0 | 19,368 | 0 | 0 | Against |
| ArchPoint Investors | 14,095 | 0 | 0 | 0 | For |
| Ramsay, Stattman, Vela & Price, Inc. | 11,381 | 0 | 0 | 0 | For |
| CHELSEA COUNSEL CO | 4,670 | 0 | 0 | 0 | For |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 570 | 0 | 0 | 0 | For |
Reported under meeting date 2026-03-23; no official results on file for that date.
0.1% fund support · no official result
The 3 asset managers below cast 0.1% of the shares they voted on this item FOR (922 for, 1,527,065 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0 | 1,525,911 | 0 | 0 | Against |
| Spinnaker ETF Series | 0 | 1,154 | 0 | 0 | Against |
| Robertson Stephens Wealth Management, LLC | 922 | 0 | 0 | 0 | For |
Meeting held 2026-05-20.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (491 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Members Trust Co | 318 | 0 | 0 | 0 | For |
| Ballew Advisors, Inc | 173 | 0 | 0 | 0 | For |
Ranked by the number of Thermo Fisher Scientific Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 371,621,465 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 10.07% |
| 2 | BlackRock | 7.01% |
| 3 | Fidelity | 6.46% |
| 4 | Capital Group | 6.00% |
| 5 | T. Rowe Price | 2.95% |
| 6 | State Street | 2.85% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.25% |
| 8 | Putnam | 1.82% |
| 9 | Charles Schwab | 1.56% |
| 10 | Capital Research Global Investors | 1.19% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 9.19% | 13F |
| BlackRock | 8.19% | 13F |
| State Street | 4.50% | 13F |
| Morgan Stanley | 3.20% | 13F |
| FMR (Fidelity) | 2.90% | 13F |
| Franklin Templeton | 1.83% | 13F |
| JPMorgan Chase | 1.83% | 13F |
| T. Rowe Price | 1.70% | 13F |
| Marc N. Casper | 0.03% | DEF14A |
| Michel Lagarde | 0.02% | DEF14A |
Percentages above are of 371,621,465 shares outstanding, as reported by Thermo Fisher Scientific Inc. on its Form 10-Q dated 2026-03-28 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Thermo Fisher Scientific Inc.’s 10-Q dated 2026-03-28. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Thermo Fisher Scientific Inc.'s shareholder meeting held 2026-05-20, in the 2025-2026 proxy season, 1,664 asset managers reported how they voted in their SEC Form N-PX filings, covering 18,323 separate fund positions. Their filings are grouped here into 18 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — An advisory vote to approve named executive officer compensation. — FOR was 32% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is not more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Thermo Fisher Scientific Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-26.
Thermo Fisher Scientific Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).